Curated News
By: NewsRamp Editorial Staff
June 11, 2025
Burcon Nutrascience Advances in Plant-Based Protein Market with New Products
TLDR
- Burcon Nutrascience's advancements in plant-based protein production and a $6.8 million agreement position it strongly in the competitive $215-392 million pea protein market.
- Burcon Nutrascience achieved first commercial production of Peazazz® C and FavaPro™, leveraging proprietary technologies for scalable, versatile plant-based protein manufacturing.
- Burcon Nutrascience's sustainable, high-performance proteins contribute to a healthier planet by meeting the growing demand for plant-based nutrition with superior taste and functionality.
- Discover how Burcon Nutrascience is revolutionizing the food industry with its next-generation pea and fava proteins, now in commercial production.
Impact - Why it Matters
This news highlights Burcon Nutrascience's progress in the competitive plant-based protein market, showcasing its ability to innovate and scale production to meet growing consumer demand for sustainable and high-performance protein alternatives. The company's advancements and financial strategies signal its potential to become a key player in the industry, impacting investors, consumers, and the broader food technology sector.
Summary
Burcon Nutrascience Corporation has made significant strides in its commercialization strategy, achieving first commercial production of its next-generation Peazazz® C pea protein and introducing FavaPro™ fava protein within 90 days of commissioning its Galesburg facility. The company has completed initial shipments of Peazazz® C, supported by strong market reception, and entered into a $6.8 million multi-year production agreement, setting the stage for its 2025 revenue target of $1–3 million. Burcon's Galesburg facility leverages proprietary protein technologies for scalable production across various plant-based proteins, tapping into a pea protein market estimated at US$215 million to US$392 million.
At the 2025 IFT FIRST Annual Event & Expo, Burcon showcased its diverse protein portfolio, including pea, fava, canola, and sunflower proteins, attracting significant interest from potential customers. The company is focusing on securing long-term supply agreements and expanding its product pipeline, with a growing number of prospects in late-stage evaluations. Financially, Burcon reported a 44% increase in revenues to $0.34M in 1Q26, despite a net loss of $3.5M, as it invests in scaling operations and reducing R&D and G&A expenses. With $4.2M in cash and a clear path to profitability, Burcon is poised for growth in the plant-based protein sector.
Source Statement
This curated news summary relied on content disributed by Reportable. Read the original source here, Burcon Nutrascience Advances in Plant-Based Protein Market with New Products
